KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $671,000 | -30.1% | 50,000 | -50.0% | 1.32% | +58.6% |
Q4 2017 | $960,000 | -12.6% | 100,000 | 0.0% | 0.83% | -15.7% |
Q3 2017 | $1,098,000 | +21.3% | 100,000 | 0.0% | 0.98% | +18.8% |
Q2 2017 | $905,000 | +104.8% | 100,000 | +102.0% | 0.83% | +142.4% |
Q1 2016 | $442,000 | -44.4% | 49,500 | -17.5% | 0.34% | -34.9% |
Q4 2015 | $795,000 | +412.9% | 60,000 | +306.8% | 0.52% | +510.5% |
Q3 2015 | $155,000 | -66.2% | 14,750 | -1.7% | 0.09% | -77.7% |
Q1 2015 | $459,000 | – | 15,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |